COMORBIDITIES AS AN ELEMENT OF MULTIDIMENSIONAL PROGNOSTIC ASSESSMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

作者: Brodnicka I , Parysek H , Batura-Gabryel H , Grabicki M

DOI:

关键词:

摘要: Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation, some significant extrapulmonary effects, and important comorbidities. The BODE index, a multidimensional scale, has been proposed to better identify severity of the predict survival. goal study was evaluate prevalence concomitant diseases in patients with COPD assess correlations between comorbidities index. Eighty were enrolled. They at least 40 years old had more than 10-year history smoking. most frequent were: systemic hypertension, edema lower limbs, movement disorders, varices limbs. Subjects higher scores index significantly greater arrhythmias episodes pneumonia. Evident correlation observed low FEV(1) We also found that exacerbations COPD. Comorbidities are very common Results indicate close connection comorbidities, which suggests these conditions may aggravate course increase risk mortality.

参考文章(12)
Holownia A, Chyczewska E, Noparlik J, Braszko Jj, Mroz Rm, Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. Journal of Physiology and Pharmacology. ,vol. 58, pp. 453- 460 ,(2007)
Reznick Az, Bar-Shai M, Burbea Z, Hasnis E, Cigarette smoke-induced NF-kappaB activation in human lymphocytes: the effect of low and high exposure to gas phase of cigarette smoke. Journal of Physiology and Pharmacology. ,vol. 58, pp. 263- 274 ,(2007)
Timo Keistinen, Tuili Tuuponen, Sirkka-Liisa Kivelä, Sirkku Vílkman, Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital Respiration. ,vol. 64, pp. 281- 284 ,(1997) , 10.1159/000196687
Nicholas R. Anthonisen, John E. Connett, Paul L. Enright, Jure Manfreda, Hospitalizations and mortality in the Lung Health Study. American Journal of Respiratory and Critical Care Medicine. ,vol. 166, pp. 333- 339 ,(2002) , 10.1164/RCCM.2110093
Thomas L. Petty, Definition, epidemiology, course, and prognosis of COPD. Clinical Cornerstone. ,vol. 5, pp. 1- 10 ,(2003) , 10.1016/S1098-3597(03)90003-2
L. P McGarvey, M. John, J. A Anderson, M. Zvarich, R. A Wise, Ascertainment of Cause-Specific Mortality in COPD -- Operations of the TORCH Clinical Endpoint Committee Thorax. ,vol. 62, pp. 411- 415 ,(2007) , 10.1136/THX.2006.072348
Joan B. Soriano, George T. Visick, Hana Muellerova, Nassrin Payvandi, Anna L. Hansell, Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care Chest. ,vol. 128, pp. 2099- 2107 ,(2005) , 10.1378/CHEST.128.4.2099
A. G. N. Agusti, Systemic effects of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. ,vol. 2, pp. 367- 370 ,(2005) , 10.1513/PATS.200504-026SR
J.G van Manen, P.J.E Bindels, C.J IJzermans, J.S van der Zee, B.J.A.M Bottema, E Schadé, Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40 Journal of Clinical Epidemiology. ,vol. 54, pp. 287- 293 ,(2001) , 10.1016/S0895-4356(01)00346-8
Bartolome R. Celli, Claudia G. Cote, Jose M. Marin, Ciro Casanova, Maria Montes de Oca, Reina A. Mendez, Victor Pinto Plata, Howard J. Cabral, The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease The New England Journal of Medicine. ,vol. 350, pp. 1005- 1012 ,(2004) , 10.1056/NEJMOA021322